Artikel ; Online: Cholesteatoma gene expression of matrix metalloproteinases and their inhibitors by RT-PCR.
Brazilian journal of otorhinolaryngology
2012 Band 78, Heft 3, Seite(n) 116–121
Abstract: Unlabelled: Acquired middle ear cholesteatoma is a benign keratinizing hyperproliferative squamous epithelial lesion that may result in the destruction of the bone structures surrounding the temporal bone. Recent studies show that variations in cellular ...
Abstract | Unlabelled: Acquired middle ear cholesteatoma is a benign keratinizing hyperproliferative squamous epithelial lesion that may result in the destruction of the bone structures surrounding the temporal bone. Recent studies show that variations in cellular production of matrix metalloproteinases (MMPs) and their specific inhibitors (TIMPs) contribute to the pathophysiology of cholesteatoma. Objective: This study aims to analyze the use of RNA amplification tests to evaluate the expression of MMP and TIMP isoforms in cholesteatomas and their correlation with disease severity. Materials and methods: This is a prospective study. Nineteen cholesteatoma cases at different stages were selected. RNA collected from biopsy specimens was submitted to reverse transcription polymerase chain reaction (RT-PCR) for semiquantitative amplification of MMP2, MMP3, MMP9, MMP13 and TIMP1. Results: Six cholesteatomas were positive for at least one of the studied genes. Four samples amplified a single gene (MMP2 or MMP13) and two samples amplified three genes (MMP2, TIMP1 and MMP3 or MMP13). No sample amplified MMP9. Conclusion: RT-PCR can be used to assess MMP and TIMP gene expression in cholesteatomas despite technical difficulties. Gene expression profiles could not be related to disease severity. |
---|---|
Mesh-Begriff(e) | Adolescent ; Adult ; Aged ; Audiometry ; Biomarkers/analysis ; Child ; Child, Preschool ; Cholesteatoma, Middle Ear/complications ; Cholesteatoma, Middle Ear/enzymology ; Cholesteatoma, Middle Ear/genetics ; Gene Expression/genetics ; Hearing Loss/diagnosis ; Hearing Loss/etiology ; Humans ; Matrix Metalloproteinases/genetics ; Matrix Metalloproteinases/metabolism ; Middle Aged ; Prospective Studies ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Severity of Illness Index ; Tissue Inhibitor of Metalloproteinase-1/genetics ; Tissue Inhibitor of Metalloproteinase-1/metabolism ; Tomography, X-Ray Computed ; Young Adult |
Chemische Substanzen | Biomarkers ; RNA, Messenger ; Tissue Inhibitor of Metalloproteinase-1 ; Matrix Metalloproteinases (EC 3.4.24.-) |
Sprache | Portugiesisch |
Erscheinungsdatum | 2012-04-03 |
Erscheinungsland | Brazil |
Dokumenttyp | Journal Article |
ZDB-ID | 2428110-4 |
ISSN | 1808-8686 ; 1808-8694 |
ISSN (online) | 1808-8686 |
ISSN | 1808-8694 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 6641: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.